Li‐Xi Yang

2.3k citations
35 papers · 1.9k indexed · 1 hit paper · h-index 18
Topics
Cancer therapeutics and mechanisms (11 papers)Cancer-related Molecular Pathways (5 papers)Cancer Treatment and Pharmacology (5 papers)
Partner nations
United StatesChina

In The Last Decade

Li‐Xi Yang

35 papers receiving 1.9k citations

Hit Papers

Gamma-H2AX - a novel biomarker for DNA double-strand breaks.20082026201420202008250500750

Peers

Li‐Xi Yang
Comparison fields: 5 of 128
  • Molecular Biology 1.1k
  • Oncology 512
  • Cancer Research 246
  • Pulmonary and Respiratory Medicine 215
  • Immunology 210
Replace Seok‐Il Hong with:
Seok‐Il Hong South Korea
Rakesh Naidu Malaysia
Dimitrios T. Trafalis Greece
Anait S. Levenson United States
Mamoru Shoji United States
Mohamed Ali‐Seyed Saudi Arabia
Abhijit Mazumdar United States
Bruna Pucci Italy
Hong‐Duck Um South Korea
Li‐Xi Yang relative to Seok‐Il Hong South Korea Seok‐Il Hong's profile →
Citations per field
00.5×1.5×2.4×
Seok‐Il Hong · 1×
Citations per year

Countries citing papers authored by Li‐Xi Yang

Since Specialization
Citations

This map shows the geographic impact of Li‐Xi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Xi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Xi Yang more than expected).

Fields of papers citing papers by Li‐Xi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Xi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Xi Yang. The network helps show where Li‐Xi Yang may publish in the future.

Co-authorship network of co-authors of Li‐Xi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Xi Yang. A scholar is included among the top collaborators of Li‐Xi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Xi Yang. Li‐Xi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2 2
3
Recent developments in radiosensitization.
39
4
Radiation-associated Cardiac Injury.
17
5
Cardiotoxicity of molecular-targeted drug therapy.
11
6 17
7
Current status in chemotherapy for advanced pancreatic adenocarcinoma.
37
8 8
9
Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog.
18
10 51
11
A novel camptothecin analog with enhanced antitumor activity.
7
12 34
13 2
14 18
15 26
16
Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
128
17 6
18 118
19 47
20 12

About Li‐Xi Yang

Li‐Xi Yang is a scholar working on Toxicology, Oncology and Cancer Research, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (11 papers), Cancer-related Molecular Pathways (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Toxicology (92 citations), Oncology (512 citations) and Cancer Research (246 citations). Li‐Xi Yang has collaborated with scholars based in United States and China. Frequent co-authors include Owen Chan, Huynh Cao, Evan B. Douple, Huijuan Wang, Huijuan Wang, Russell W. Driver, Xiandao Pan, Tianyi Tang, Caspian Oliai and Julia A. O’Hara. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026